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Abstract
We describe 19 unrelated individuals with submicroscopic deletions involving 10p15.3
characterized by chromosomal microarray (CMA). Interestingly, to our knowledge, only two
individuals with isolated, submicroscopic 10p15.3 deletion have been reported to date; however,
only limited clinical information is available for these probands and the deleted region has not
been molecularly mapped. Comprehensive clinical history was obtained for 12 of the 19
individuals described in this study. Common features among these 12 individuals include:
cognitive/behavioral/developmental differences (11/11), speech delay/language disorder (10/10),
motor delay (10/10), craniofacial dysmorphism (9/12), hypotonia (7/11,), brain anomalies (4/6)
and seizures (3/7). Parental studies were performed for nine of the 19 individuals; the 10p15.3
deletion was de novo in seven of the probands, not maternally inherited in one proband and
inherited from an apparently affected mother in one proband. Molecular mapping of the 19
individuals reported in this study has identified two genes, ZMYND11 (OMIM# 608668) and
DIP2C (OMIM# 611380) (UCSC Genome Browser), mapping within 10p15.3 which are most
commonly deleted. Although no single gene has been identified which is deleted in all 19
individuals studied, the deleted region in all but one individual includes ZMYND11 and the
deleted region in all but one other individual includes DIP2C. There is not a clearly identifiable
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phenotypic difference between these two individuals and the size of the deleted region does not
generally predict clinical features. Little is currently known about these genes complicating a
direct genotype/phenotype correlation at this time. These data however, suggest that ZMYND11
and/or DIP2C haploinsufficiency contributes to the clinical features associated with 10p15
deletions in probands described in this study.
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INTRODUCTION
Two distinct clinical phenotypes have been described in association with deletion of
chromosome 10p. Hypoparathyroidism, sensorineural deafness, and renal dysplasia
syndrome (HDRS, also known as Barakat syndrome, OMIM#146255) is caused by
haploinsufficiency of the GATA3 gene (OMIM#131320) on chromosome 10p14 (~8 Mb
from 10pter). Deletions proximal to this region have been associated with a clinical
phenotype described as DiGeorge syndrome/velocardiofacial syndrome complex-2 (DGS2,
OMIM#601362), with a proposed critical region mapping to 10p14-p13. Lindstrand et al.
recently performed molecular characterization by array CGH of four probands with
overlapping deletions including 10p15. This study identified two critical regions, defined by
minimal regions of overlap. The first critical region spans 1.6 Mb within 10p15.1 (from 4.7
Mb to 6.3 Mb from 10pter, UCSC March 2006 build NCBI36/hg18) and is associated with
intellectual disability and language impairment. The second critical region spans 4.3 Mb
within 10p14 (from 6.3 Mb to 10.6 Mb from 10pter, UCSC March 2006 build NCBI36/
hg18) and is associated with autism and dysmorphic features; this region does not include
the DGS2 locus.
The focus of this study is submicroscopic deletion of 10p15.3. Interestingly, to our
knowledge, only two probands with isolated, submicroscopic 10p15.3 deletions have been
reported. This study describes 19 unrelated individuals with submicroscopic deletions
involving 10p15.3 characterized by chromosomal microarray (CMA), comprising the first
such cohort reported to date. Comprehensive clinical history, available for 12 of the 19
individuals described in this study, in combination with detailed molecular mapping,
allowed the first assessment of genotype/phenotype correlations among individuals with
submicroscopic deletions within 10p15.3. Molecular mapping of the 19 individuals reported
in this study has identified two genes, ZMYND11 (OMIM# 608668) and DIP2C (OMIM#
611380), mapping within 10p15.3 which are most commonly deleted. Although no single
gene has been identified which is deleted in all 19 individuals studied, the deleted region in
all but one individual includes ZMYND11 and the deleted region in all but one other
individual includes DIP2C (Probands 10 and 17, respectively). There is not a clearly
identifiable phenotypic difference between these two individuals (Probands 10 and 17) and
the size of the deleted region does not generally predict clinical features in this cohort. Little
is currently known about these genes complicating a direct genotype/phenotype correlation
at this time. These data however, suggest that ZMYND11 and/or DIP2C haploinsufficiency
contributes to the clinical features associated with 10p deletions in our probands.
CLINICAL REPORTS
Proband 1
This male proband (previously reported as Patient 27, DeScipio et al., 2008) was born at full
term to a 37-year-old G5P2 mother with an Apgar score of 9 at both 1 and 5 minutes. An
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amniocentesis, performed for advanced maternal age, was normal. His birth weight was 2.76
kg (10th-25th centile). He remained in the neonatal intensive care unit for 5 days due to poor
feeding and emesis. He had mild jaundice. A heart murmur was noted; an echocardiogram
revealed bicuspid aortic valve. He had thickened superior helices, micrognathia, and fifth
finger clinodactyly.
At 5 months of age, he was noted to have hypotonia, mild gross motor delay, and mitral
valve regurgitation. At 8 months of age, developmental delay persisted and magnetic
resonance imaging (MRI) of the brain demonstrated underoperculization. At 11 months of
age, he was reevaluated by a cardiologist who felt that he had an innocent heart murmur,
possibly due to an abnormal pulmonary valve which can not be seen on echocardiogram. At
one year of age, he had a normal audiology examination. At 3 years of age, he was walking,
able to feed himself, and helped with dressing. He was not yet toilet trained. Developmental
evaluation revealed persistence of hypotonia, some questionable cognitive delays, as well as
speech and some motor delays. He had approximately fifteen words, as well as using some
signs to communicate. He continues to have a strong gag reflex and increased emesis, often
behaviorally initiated. He was receiving speech, occupational, and physical therapy.
Craniofacial dysmorphism was noted (Fig 1A) with inverted epicanthal folds, long eyelashes
and the appearance of hypertelorism. His nasal bridge was depressed, ears appeared normal
with slightly thickened superior helices and there was a broad philtrum. The palate was
slightly high with a normal tongue and a somewhat averted lower lip.
He developed partial complex seizures that have been well controlled on low dose tegretol.
A repeat MRI of the brain demonstrated normal anatomy with resolution of the previously
identified underoperculization. Some concern was raised on this imaging over a possible
craniovertebral junction anomaly and subsequent spinal radiographs and computed
tomography (CT) with 3-D reconstruction demonstrated a hypoplastic arch of C1,
asymmetrical occipital condyles (malformed on right) and shortening of the clivus.
Standard (G-banded) karyotype was interpreted as normal (46,XY); however, FISH analysis
of all subtelomeres detected a deletion of the 10p15.3 subtelomere. SNP array confirmed
this de novo 10p15.3 interstitial deletion refining the deleted region to 292,414 bp (chr10:
281,134- 573,548, hg18) (Table II).
Proband 2
This female proband (previously reported as Case 98, Ravnan et al., 2006 and Patient 28,
DeScipio et al., 2008) was born at 41 1/7 weeks gestation after induced labor to a 24-year-
old G3P2 Caucasian mother with an Apgar score of 9 at both 1 and 5 minutes, weight 3030g
(25th centile), length 51.5 cm (75th centile) head circumference 35 cm (50th centile), and
chest circumference 32.5 cm (50th centile). IUGR was noted during the pregnancy. At birth
she was noted to have mild jaundice, redundant hymenal tissue and a ventral hernia superior
to the umbilicus that was surgically corrected. She had hypotonia of the lower extremities
and a sacral dimple. X-rays and ultrasound of the spine revealed no vertebral anomalies, a
mildly enlarged thecal sac and a very narrow sinus tract extending from the thecal sac to the
sacral dimple. A computed tomography (CT) scan of the brain showed a mild prominence of
the extra-axial cerebrospinal fluid (CSF) spaces bilaterally, most likely representing benign
external hydrocephalus.
At three months of age, she developed a urinary tract infection and was found to have
bilateral grade I hydronephrosis and mild left ureterectasis. Follow-up renal ultrasound at 15
months showed interval resolution of the hydronephrosis. She had gastroesophageal reflux
for the first few months of life. She also developed a feeding aversion and chronic
constipation. She underwent surgery for bilateral blocked nasal lacrimal ducts bilaterally.
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At 18 months, she was able to walk with minimal assistance. Physical therapy examination
revealed a gross motor quotient of 70 on the Peabody test at 19 months. Her skills ranged
from 10-14 months with standing and walking considered the greatest areas of delay. Her
speech was delayed.
At 1-year, 11-months of age, her height and weight were at the 3rd centile with head
circumference at the 75th. She had fine blonde hair, a triangular appearance to her face and a
prominent forehead (Fig. 1B).
Standard (G-banded) karyotype was interpreted as normal (46,XX); however, FISH analysis
of all subtelomeres detected a deletion of the 10p15.3 subtelomere. SNP array confirmed
this apparently terminal de novo 10p15.3 deletion refining the deleted region to 487,155 bp
(chr10: 103,934-591,089, hg18) (Table II).
Proband 3
This female proband had developmental delay. Additional clinical information is not
available. Standard (G-banded) karyotype was interpreted as normal (46,XX); however,
SNP array identified an apparently terminal 2,138,166 bp deletion within 10p15.3 (chr10:
62,747-2,200,913, hg18) (Table II). It is unknown whether this deletion is inherited or de
novo.
Proband 4
On exam at age 7 years, this male proband's height was 119.5 cm (27th centile), weight was
24.4 kg (60th centile) and he was macrocephalic (OFC, 55.4 cm). He had global
developmental delay, attention deficit hyperactivity disorder (ADHD), aggression and
asthma. . He had behavioral problems including acting out, aggression towards himself and
others and lack of awareness of danger and stranger anxiety. He had sleep disturbance with
nocturnal myoclonic jerks (not epileptic) and possible obstructive sleep apnea; he is being
evaluated for seizures due to his mother's concern of periods (lasting ~15 seconds) in which
he does not respond to voice but will jump if touched. He receives speech therapy. At 3 or 4
years of age he had tonsil and adenoidectomy. No craniofacial dysmorphism or
abnormalities of the spine, chest, abdomen, lungs (clear to auscultation, bilaterally), heart
(normal rate and rhythm and no murmurs) or dysmorphic features of the extremities were
noted (Fig. 1C, D). On dermatologic exam, no birth marks were noted. On neurologic exam,
he had decreased muscle tone, but good power. Pupils were equal, round and reactive to
light bilaterally. His extraocular movements were intact. His reflexes were brisk but
symmetric. He had normal gait. He had poor dentition and a normal palate. There were no
records of an audiology evaluation. His father had a family history of lung cancer and
reading problems. His mother had a family history of cancer and intellectual disability.
Standard (G-banded) karyotype was interpreted as normal (46,XY); however, SNP array
identified a 637,849 bp interstitial deletion within 10p15.3 (chr10: 101,955-739,804, hg18)
(Table II). FISH analysis of this proband's mother also revealed a 10p15.3 deletion. This
proband's mother (Fig. 1C) has not yet had a formal clinical evaluation; however, she has
significant learning differences requiring special education services in school and requires
assistance with an outside advocate to attend to her son's needs at school.
Proband 5
This male proband was born at term and weighed 2863g. On exam at age 10 years, his
height was 127.7 cm (<3rd centile), weight was 25.5 kg (4th centile) and he was
normocephalic. He had mild intellectual disability (not Autistic spectrum disorder),
developmental articulation disorder and significant mixed receptive and expressive language
disorder and hypospadia. He had normal muscle tone and strength. No craniofacial
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dysmorphism or abnormalities of the hands, feet, spine or heart were noted. Oligonucleotide
array identified an apparently terminal de novo 2,250,389 bp deletion within 10p15.3
(chr10:214,559- 2,464,948, hg18) (Table II).
Proband 6
On exam at age 5 years, this male proband's height was 108.31 cm (14th centile), weight was
16.9 kg (9th centile) and he was normocephalic. He had very mild epicanthal folds and
pointed chin. He had hypotonia and hyporeflexia. He had global developmental delay, fine
and gross motor delays, developmental coordination disorder, receptive and expressive
language disorder and a very small arachnoid cyst in the medial temporal lobe. No
abnormalities of the hands, feet or heart (normal rate and rhythm and no murmurs) were
noted. Oligonucleotide array identified an apparently terminal 460,631 bp deletion within
10p15.3 (chr10: 170772- 631403, hg18) (Table II). It is unknown whether this deletion is
inherited or de novo.
Proband 7
This male proband was born at 38 weeks gestation after induced vaginal delivery; his weight
was 3402g. Pregnancy history includes a small amount of bleeding early in the pregnancy
and diagnosis of a diaphragmatic hernia. His mother denies tobacco, alcohol or recreational
or prescription drug use during the pregnancy. There was no maternal history of illness,
fever, rash or radiation exposure during the pregnancy. He had surgical repair of this
diaphragmatic hernia on day four of life; he was subsequently on a ventilator for
approximately 3 weeks and discharged home at a month of age.
On exam at age 5 years, his height was 105.5 cm (25th), weight was 18.2kg (25-50th) and
head circumference was 53cm (75th). He had partial complex seizures, diaphragmatic hernia
and developmental, motor and language delays. He had craniofacial dysmorphism including
plagiocephaly and a normally positioned nose with prominent columella and hypoplastice
alae. He had bilateral fifth finger clinodactyly and pes planus with bilateral clinodactyly of
toes 3, 4 and 5. Palm length was 6.5 cm (3rd to 25th centile); third finger length was 5 cm
(25th centile). He had fetal fat pads on all digits. Finger and toenails were normal; palmar
and plantar creases were normal. Pupils were equal, round and reactive to light with intact
extraocular movements. Sclera was white. Interpupillary distance was 6 cm (>97th centile).
Innercanthal distance was 3.25 cm (97th centile). Ears were normally shaped; ear length was
5.5 cm (50-75th centile). Oral mucosa was pink and moist without lesions. The palate was
intact and mildly narrow. He had a single uvula. Dentition was normal except for caries.
Neck was supple and without adenopathy. Chest was symmetric with no pectus carinarum or
excavatum. Breasts were normal. Lungs were clear to auscultation with equal bilateral
breath sounds. Normal heart rate and rhythm was present with I/VI systolic murmur. Spine
was straight without palpable lesions. Abdomen was soft, nontender and nondistended with
no masses or hepatosplenomegaly; a scar was consistent with surgery. Genitalia were
immature male with shawl scrotum; testes descended bilaterally. Anus was normally placed.
He had full range of motion of all joints. Skin had no lesions. He had deep tendon reflexes
2+ bilaterally in the upper and lower extremities. He had no sustained ankle clonus.
Babinski signs were negative. He had a wide-based gait and clumsy running.
He was using single words between 2 and 3 years of age; he began using two word phrases
between 3 and 4 years of age. At age 5 years, he was still using one or two word sentences.
He also had marked gross motor delay; he is unable to run well or ride a bicycle. His fine
motor skills were less delayed; he can grasp a pencil and use scissors. He is affectionate,
social and hyperactive. He crawled between 17 and 18 months of age; he walked
independently between two and two and a half years of age. Neurologic evaluation at 6
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years and 6 months demonstrated significant problems with expressive and receptive
language among other delays. He had a normal brain MRI.
He is the third child of his parents; he has two healthy sisters. His mother is of Italian
ancestry and is in good health. His father is of Dutch, German and Sweedish ancestry; he is
in good health. There is no family history of consanguinity, multiple miscarriages or
intellectual disability. FISH analysis detected a deletion of the 10p15.3 subtelomere; SNP
array confirmed this apparently terminal de novo 1,168,170bp deletion within 10p15.3
(chr10: 62,797- 1,230,967, hg18) (Table II).
Proband 8
This 3-year-old male proband was referred for cytogenetic testing due to developmental
delay (i.e., delayed motor skills) and hypotonia. Additional clinical information is not
available. Oligonucleotide array identified an apparently terminal 2,964,573 bp deletion
within 10p15.3 (chr10: 126,361-3,090,934, hg18) (Table II). It is unknown whether this
deletion is inherited or de novo.
Proband 9
On exam at age 1 year, 9 months, this female proband's height was 78.9 cm (10th centile),
weight was 8.25 kg (<3rd centile) and she was normocephalic. She had craniofacial
dysmorphism including bilateral epicanthus inversus, epicanthal folds, wide nasal bridge,
tall/bossed forehead, mild micrognathia, slightly high anterior palate, flat facial profile and
mild tenting of the upper lip (Fig. 1E). She had developmental delay, hypotonia,
gastroesophageal reflux disease (GERD), constipation, kyphosis, hypoplastic nipples and
frequent respiratory and serous otitis media infections. Her heart was regular, without
murmurs. No abnormalities of the ears, palmar creases, digits, nails, hands, or feet were
noted. Oligonucleotide array identified a 446,016 bp de novo interstitial deletion within
10p15.3 (chr10:284,172-730,188, hg18) (Table II). Quantitative polymerase chain reaction
(Q-PCR) of DIP2C confirmed the deletion in this proband and showed normal results in
parental samples (data not shown).
Proband 10
On exam at age 7 years, this female proband's height was 103.3 cm, weight was 15.4 kg and
head circumference was 51.5 cm. She had craniofacial dysmorphism including bifrontal
narrowing of forehead, normally spaced, mildly downslanting eyes, deep set mildly
upturned nose, high palate, downturned corners of the mouth, overfolded ears normal in
position with no pits or tags. She had growth delay, mild hypotonia, hyperextensible hands,
webbed toes, nasal speech and anxiety accompanied by some repetitive behaviors. There
was a history of recurrent strep throat and enlarged tonsils. Audiologic evaluation was
within normal limits. She had a history of a heart murmur that resolved. It is unclear whether
this proband had developmental delay or language/speech delay due to her recent adoption
and long history of neglect. She did not have seizures; no brain imaging had been
performed. Oligonucleotide array identified a 278,240 bp interstitial deletion within 10p15.3
(chr10: 426,747-704,987, hg18) (Table II). It is unknown whether this deletion is inherited
or de novo. Of note, this is the only proband within this cohort of 19 individuals whose
10p15 deleted region does not include the gene ZMYND11 (Fig. 2).
Proband 11
This two year old female proband was referred for cytogenetic testing due to developmental
delay. Additional clinical information is not available. Whole genome BAC array identified
DeScipio et al. Page 6
Am J Med Genet A. Author manuscript; available in PMC 2013 September 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
an apparently terminal 3,995,011 bp deletion within 10p15.3 (chr10: 50,001-4,045,012,
hg18) (Table II). It is unknown whether this deletion is inherited or de novo.
Proband 12
This 6-year-old male proband was referred for cytogenetic testing due to developmental
delay and seizures. Additional clinical information is not available. Oligonucleotide array
identified a 216,371 bp interstitial deletion within 10p15.3 (chr10: 144,508-360,879, hg18)
(Table II). It is unknown whether this deletion is inherited or de novo.
Proband 13
On exam at age 12 years, this male proband's height was 154.1 cm (75th centile), weight was
68.2 kg (>97th centile) and head circumference was 56 cm (98th centile). His birth weight
was 2.35 kg at 28 weeks gestation. He had craniofacial dysmorphism including frontal
bossing, down-slanting palpebral fissures, bilateral epicanthal folds, stellate iris pattern,
wide nasal bridge, prominent incisors and thin whitish eyebrows (Fig. 1F). He walked at 2
years of age and had speech at 6 years of age. At 10 years of age, his IQ was at 4 to 5-year-
old level. He had tapered fingers with short, brittle nails, alopecia totalis, attention deficit
hyperactivity disorder (ADHD), anger and aggression, large testes with deep rugae, and
some tremors and incidental myoclonus. He did not have growth delay, hypotonia or
seizures and had not had brain imaging. Oligonucleotide array identified an apparently
terminal 336,199 bp deletion within 10p15.3 (chr10: 115,543-451,742, hg18) (Table II). It is
unknown whether this deletion is inherited or de novo.
Proband 14
This 3-year-old female proband was referred for cytogenetic testing due to developmental
delay. Additional clinical information is not available. Oligonucleotide array identified an
181,800 bp interstitial deletion within 10p15.3 (chr10: 215,071- 396,871, hg18) (Table II). It
is unknown whether this deletion is inherited or de novo.
Proband 15
This 23-year-old female proband was referred for cytogenetic testing due to pervasive
developmental delay (PDD). Additional clinical information is not available.
Oligonucleotide array identified an apparently terminal 552,443 bp deletion within 10p15.3
(chr10: 128,680- 681,123, hg18) (Table II). It is unknown whether this deletion is inherited
or de novo.
Proband 16
On exam at age 8 years, this male proband's height was <10th centile, weight was at the 90th
centile and head circumference was at the 90th centile. His birth weight was 2320 g (<10th
centile). He had craniofacial dysmorphism including synophrys, thick lower lip, thickened
ears and relative macrocephaly (Fig. 1G). He did not have hypotonia or seizures and nuclear
magnetic resonance (NMR) brain imaging was normal. He had developmental delay, autistic
behavior, stereotypy and developmental and speech delay. He had prenatal onset short
stature, patchy pigment of skin/café-aulait spots and inverted nipple. Oligonucleotide array
identified an apparently terminal de novo 1,633,037 bp deletion within 10p15.3 (chr10:
115,544-1,748,581, hg18) (Table II).
Proband 17
This female proband was born at 35 weeks gestation; her birth weight was 1500 g (-2.5SD,
<3rd centile). Pregnancy was complicated by oligohydramnios and intrauterine growth
retardation (IUGR). On exam at age 2 years and 5 months, her height was 83 cm (-2.5SD),
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weight was 10.7kg (-1SD) and head circumference was 45 cm (-2.5SD). On exam at age 6
years and 1 month, her height was 105.9 cm (-2.7 SD), weight was 14.8 kg (-2 SD for
height) and head circumference was 47 cm (-2.4 SD). She had craniofacial dysmorphism
including short palpebral fissures, depressed nasal bridge, epicanthic folds, mild cleft uvula,
thin/slow growing hair, smooth philtrum, broad mouth and thin upper lip vermilion (Fig.
1H,I). At birth, a persistent foramen ovale was detected. She had overriding toes (including
clinodactyly) and one depigmentated and one hyperpigmented nevus on the abdomen. She
did not have epileptic insults. She had intellectual disability and motor delay; she walked at
18 months and at 6 years and 1 month of age was doing well running and swimming. She
had speech delay with no speech at 2 years and 5 months of age and a few words at 6 years
and 1 month of age. Standard karyotype was interpreted as normal (46, XX); however,
multiplex ligation-dependent probe amplification (MLPA) detected a deletion of the 10p15.3
subtelomere. SNP array confirmed this apparently terminal de novo 154,558 bp deletion
within 10p15.3 (chr10: 148,946-303,504, hg18) (Table II). Of note, this is the only proband
within this cohort of 19 individuals whose 10p15 deleted region does not include the gene
DIP2C (Fig. 2). Minimal deletion boundaries, based on array data, are from the most distal
SNP probe on the array (rs11253562 at chr10:148,946, hg18) to the most proximal deleted
probe (rs4880568 at chr10:303,504, hg18), resulting in a minimal deletion of 154,558 bp
(chr10: 148,946-303,504, hg18). The maximal deletion boundaries, based on array data, are
from 10pter (i.e., chr10: 1) to the proximal, non-deleted probe (rs10903844 at
chr10:317,582-318,082, hg18) resulting in a maximal deletion of 317,582 bp
(chr10:1-317,582, hg18). Based on array data, the proximal deletion breakpoint lies within a
~15,000 bp region between rs4880568 (distally) and rs10903844 (proximally). MLPA
(MRC-Holland, Amsterdam, Netherlands) further substantiated the deletion boundaries:
probe P070, mapping within ZMYND11, was deleted while proximal probe P036B,
mapping within DIP2C, was present (data not shown). This proximal deletion boundary was
further mapped with a FISH probe (GS-23B11, with in BAC RP11-486H9) containing
DIP2C; this probe was not deleted. Furthermore, a SNP (rs10903844) mapping between
ZMYND11 and DIP2C was not deleted by SNP array. In summary, ZMYND11 lies within
the deleted region while DIP2C does not.
Proband 18
On exam at age 48 years, this male proband's height was 163 cm (5th-10th centile), weight
was 92 kg (>97th centile) and head circumference was 58.5 cm (>97th centile). He was the
second child to a nonconsanguineous couple. His birth weight was 2100 g (3rd centile) at 36
weeks gestation. He was a poor feeder. He had mild hemiparesis on the left since birth. He
had craniofacial dysmorphism including high forehead, arched eyebrows, depressed nasal
bridge, downturned corners of the mouth, thin upper lip vermilion, small eyes, and large
low-set ears (Fig. 1J). He had growth delay and moderate intellectual disability. He had
global psychomotor delay with independent walking at 3 years of age. He had severe
language and speech delay. He speaks with single words, a lot of repetition and no
sentences. His speech has remained stable, with no regression over the years. He had tonic
epilepsy beginning at age 14 months and severe grand mal and absences for which he
receives medication (Valproate, Carbamazepine and Primidone). He had cortical atrophy
and pachygyria of the right hemisphere; MRI, at age 42 years, revealed cortico-subcortical
atrophy of the cerebral cortex with pachygyria of the right surface. He had hypotonia
initially. At age 38 years, he had a cerebral accident, of unknown eitology. He has since
been confined to a wheelchair with spastic quadriplegia; however, his right arm and hand
have remained functional. At age 31 years, when he was still mobile, his weight was 66 kg.
He has a brother who is 16 months older, is well and has at least one son. His father is one of
6 children; his mother is one of 7 children. There is not a history of other affected family
members. This proband's standard karyotype was interpreted as normal (46,XY); however,
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oligonucleotide array identified an apparently terminal 3,706,088 bp deletion within 10p15.3
(chr10: 106,829- 3,812,917, hg18) (Table II). This deletion was not detected in the proband's
mother or brother; his father is deceased.
Proband 19
This 15-month-old female proband was referred for cytogenetic testing due to hypotonia and
delayed motor skills. Additional clinical information is not available. Oligonucleotide array
identified an apparently terminal 387,042 bp deletion within 10p15.3
(chr10:106,418-493,460, hg18) (Table II). It is unknown whether this deletion is inherited or
de novo.
METHODS
Cytogenetic and Molecular Cytogenetic Analysis
Chromosomal analysis was performed on metaphase spreads prepared from PHA stimulated
cultured peripheral blood lymphocytes using standard methods (Probands 1, 2, 3, 4, 17, 18).
Fluorescent in situ hybridization (FISH) was performed to analyze all subtelomeres using
the Multiprobe Chromoprobe T System (Cytocell Technologies Ltd., Cambridge,U.K.)
(Proband 1). Subtel FISH was also performed in Patents 2 and 7. FISH parental studies were
performed in follow up to array studies in some cases. Quantitative polymerase chain
reaction (Q-PCR) of DIP2C was performed in Proband 9 and her parents. Multiplex
ligation-dependent probe amplification (MLPA) (MRC-Holland, Amsterdam, the
Netherlands) and additional FISH studies were performed in Proband 17.
Microarray Analysis
The following array platforms (Table II) were used to analyze DNA samples from the
probands described in this study: Illumnia HumanHap550 V1 and V3 SNP arrays (Illumina,
Inc., San Diego, CA) (Probands 2 and 1, respectively), Genome-wide Human SNP Array 6.0
(Affymetrix, Santa Clara, CA) (Probands 3, 4 and 7), Custom-designed Agilent CGH array
(Probands 5 and 6), ISCA 44K CGH Array (Agilent Technologies, Paulo Alto, CA)
(Proband 8), whole-genome oligonucleotide array CGH GenomeDx microarray V3 105k
oligo (Proband 9), whole genome bacterial artificial chromosome (BAC)-based microarray
(SignatureChipWG, Signature Genomics, Spokane, WA) (Proband 11), 105K-feature
whole-genome oligonucleotide microarray (SignatureChipOS v1.0, custom-designed by
Signature Genomics, Spokane, WA, manufactured by Agilent Technologies, Santa Clara,
CA) (Probands 12 and 13), 135K-feature whole-genome oligonucleotide microarray
(SignatureChipOS v2.0, custom-designed by Signature Genomics, manufactured by Roche
NimbleGen, Madison, WI) (Probands 10, 14 and 15), 244K CGH Array (Agilent
Technologies, Paulo Alto, CA) (Proband 16), GeneChip Human Mapping 250K Nsp Array
(Affymetrix, Santa Clara, CA) (Proband 17), CytoSure ISCA 180k array (Oxford Gene
Technologies, Oxford, UK) (Proband 18) and ISCA 180K CGH Array (Agilent
Technologies, Paulo Alto, CA) (Proband 19).
RESULTS
We report on 19 unrelated probands with molecularly characterized isolated submicroscopic
overlapping deletions within 10p15.3; deletions vary in size from ~154 kb (Proband 17) to
~4 Mb (Proband 11). Parental studies were performed for 9 probands (including one family
in which only the proband's mother and brother were available for study); parental studies
were not conducted for the remaining 10 probands. The 10p15 deletion was de novo in
seven of the probands (Probands 1, 2, 5, 7, 9, 16, 17), not maternally inherited in one
proband (Proband 18), and maternally inherited in one proband (Proband 4). No other
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clinically significant copy number changes were detected by CMA in any of these
individuals.
This study describes 19 unrelated individuals with submicroscopic deletions involving
10p15.3 characterized by chromosomal microarray (CMA), comprising the first such cohort
reported to date. Facial features are similar, especially among individuals with small
10p15.3 deletions (i.e., Probands 1, 2, 4, 9, 13, 16, 17) as compared to an individual with a
large deletion (Proband 18) (Fig. 1). Comprehensive clinical history, available for 12 of the
19 individuals described in this study, in combination with detailed molecular mapping,
permitted the first assessment of genotype/phenotype correlations among individuals with
submicroscopic deletions within 10p15.3 (Table I). Common clinical findings (Table I) and
genes mapping within this deleted region are described (Fig. 2).
Molecular mapping of the 10p15 deleted region in 19 individuals reported in this study has
identified two genes, ZMYND11 (OMIM# 608668) and DIP2C (OMIM# 611380) mapping
within 10p15.3 which are most commonly deleted, according to UCSC Genome Browser
hg18 build (Fig. 2). Although no single gene has been identified which is deleted in all 19
individuals studied, the deleted region in all but one individual (Proband 10) includes
ZMYND11 and the deleted region in all but one other individual (Proband 17) includes
DIP2C. The 10p15 deleted region of seven probands (Probands, 3, 5, 7, 8, 11, 16 and 18)
also includes IDI1 (OMIM: 604055) and ADARB2 (OMIM: 602065). PFKP (OMIM:
171840) maps within the deleted region of three probands (Probands 8, 11, and 18). KLF6
(OMIM: 602053)] lies within the deleted region of two probands (Probands 11 and 18).
DISCUSSION
We report 19 unrelated probands, the first large cohort described to date, with molecularly
characterized isolated submicroscopic overlapping deletions within 10p15.3 (Fig. 2).
Comprehensive clinical history was available for 12 of the 19 individuals described in this
study, allowing the first assessment of genotype/phenotype correlations among individuals
with submicroscopic deletions within 10p15.3 (Table I). Common features among these 12
individuals include: cognitive/behavioral/developmental differences (11/11), speech delay/
language disorder (10/10), motor delay (10/10), craniofacial dysmorphism (9/12), hypotonia
(7/11), brain anomalies (4/6), and seizures (3/7) (Table I). Facial features are similar,
especially among individuals with small 10p15.3 deletions (i.e., Probands 1, 2, 4, 9, 13, 16,
17) (Fig. 1).
Only two additional probands with isolated, submicroscopic 10p15.3 deletion have been
reported [Ravnan et al., 2006]; only limited clinical information is available for these
probands and the deleted region has not been molecularly mapped. The first proband is a 10-
year-old female with multiple congenital anomalies [Ravnan et al., 2006, Case 99]. The
other reported proband is a 7-year-old female with developmental delay, attention deficit
hyperactivity disorder and seizure disorder [Ravnan et al., 2006, Case 100].
In the cohort described in this study, 10p15 deletions can be classified into one of two
groups based on the size of the deletion identified by molecular mapping. “Group A”
includes probands with a smaller deleted region of 10p15.3 (maximal size of deletion
~638kb, Proband 4); this group includes twelve probands (Probands 1, 2, 4, 6, 9, 10, 12, 13,
14, 15, 17, 19) (Fig. 2). Of note, six probands in “Group A” have interstitial 10p15.3
deletions (Probands 1, 4, 9, 10, 12, 14). “Group B” includes probands with a larger deleted
region of 10p15 (deletion size range ~1.1 to 4 Mb); this group includes seven probands
(Probands 11, 18, 8, 5, 3, 16, 7) (Fig. 2). Surprisingly, comparison of clinical finding of
probands in Group A versus Group B does not reveal striking clinical differences (Table I).
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Only two OMIM genes, ZMYND11 (OMIM: 608668) and DIP2C (OMIM: 611380) map to
the region deleted in probands in Group A. Four additional OMIM genes [IDI1 (OMIM:
604055), ADARB2 (OMIM: 602065), PFKP (OMIM: 171840) and KLF6 (OMIM:
602053)] map to the maximal region deleted in Group B. The 10p15 deleted region of seven
probands (Probands, 3, 5, 7, 8, 11, 16 and 18) also includes IDI1 (OMIM: 604055) and
ADARB2 (OMIM: 602065). PFKP (OMIM: 171840) maps within the deleted region of
three probands (Probands 8, 11, and 18). KLF6 (OMIM: 602053)] lies within the deleted
region of two probands (Probands 11 and 18).
IDI1, which catalyzes a critical activation step in the isoprenoid pathway, has been shown to
localize to peroxisomes and have reduced activity in liver of patients with the peroxisomal
deficiency diseases Zellweger syndrome (OMIM: 214100) and neonatal
adrenoleukodystrophy (OMIM: 202370) [Krisans et al., 1994]. PFK encodes the platelet
isoform of phosphofructokinase; little is known about its possible role in human disease.
KLF6 is a ubiquitously expressed zinc-finger tumor suppressor broadly involved in
differentiation and development, growth related signal transduction, cell proliferation,
apoptosis, and angiogenesis [Cho et al., 2005]. Somatic KLF6 mutations have been
identified in several human cancers, including gastric and prostate [Cho et al., 2005].
ADARB2, a member of the double-stranded RNA adenosine deaminase family of RNA-
editing enzymes, is expressed only in selected areas of the brain (such as amygdala and
thalamus) and postmitotic neurons [Chen et al., 2000]. ADARB2, an inactive enzyme, binds
single-stranded RNA and possibly plays a role in the regulation of substrate-specific RNA
editing in mammalian brains [Chen et al., 2000]. ADARB2 haploinsufficiency may play a
role in the cognitive and developmental deficits observed in individuals described in this
study.
Although no single gene has been identified which is deleted in all 19 individuals studied,
the deleted region in all but one individual (Proband 10) includes ZMYND11 (OMIM:
608668) and the deleted region in all but one other individual (Proband 17) includes DIP2C
(OMIM: 611380) (confirmed by array, FISH, and MLPA, data not shown). Comparison of
clinical findings in Proband 10 versus Proband 17 does not reveal a sticking difference
suggesting that there may be functional overlap between ZMYND11 and DIP2C.
The ZMYND11 (zinc finger MYND domain-containing protein 11) protein, first identified
by its ability to bind the adenovirus E1A protein, localizes to the nucleus and functions as a
transcriptional repressor with expression of E1A inhibiting this repression. DIP2C (disco-
interacting protein 2 homolog C) expression has been detected in all adult and fetal tissues
and specific adult brain regions examined except lung and pancreas, where expression was
low. ZMYND11 [Kurozumi et al., 1998] and DIP2C [Nagase et al., 1999] are expressed in
various tissues including the brain; however, little is known about their function, making
direct genotype/phenotype correlation currently unclear (Table III). We suggest that
ZMYND11 and/or DIP2C haploinsufficiency contributes to the clinical features associated
with 10p15 deletions in probands described in this study and that one or both of these genes
may be causative of isolated, or minimally syndromic, intellectual disability when mutated.
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Figure. 1. Individuals with 10p15.3 Microdeletion
A: Proband 1, B: Proband 2, C: Proband 4 with his mother, D: Proband 4, E: Proband 9 at
age 1 year, 11 months, F: Proband 13, G: Proband 16 at age 7 years, H: Proband 17 at age 2
years, 10 months, I: Proband 17 at age 6 years, 1 month and J: Proband 18. Age at time of
photo is noted, when known.
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Figure. 2. Deletions in individuals with 10p15.3 microdeletion
Minimal deletion boundaries (thick bar); maximal deletion boundaries (thin bar); terminal
deletions (black bars); interstitial deletions (pink bars: probands 1, 4, 9, 10, 12, 14); “Group
A”: probands with a smaller deleted region; “Group B”: probands with a larger deleted
region; OMIM and RefSeq Genes are represented below probands.
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TABLE III
Genes Most Commonly Deleted in This Cohort of Nineteen Individuals
Gene Full name Function Expression in tissues including*
ZMYND11 zinc finger MYND domain containing
protein 11
regulator of NF-kappaB
activation
brain, liver, kidney, lung, colon, testis
DIP2C disco-interacting protein 2 homolog C
(Drosophila)
Unknown brain, liver, kidney, lung, fetal heart, spleen, ear,
testis
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